Skip to main content
Back to Alumni Ventures

Alumni Ventures's Biotechnology Portfolio

Browse 8 Biotechnology companies funded by Alumni Ventures. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
8
Total Funding in Biotechnology
$120.7M

Biotechnology Portfolio Companies (8)

Export
BiopharmaBiotechnologyMedicalTherapeutics

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

San Francisco, United States
May 2026
$13.2M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyLife Science

Mapping interactions foundational to therapeutic discovery and human health.

Monmouth Junction, United States
May 2026
$12.5M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMarket Research

Blank Bio is an applied AI research company developing RNA foundation models that analyze biological sequence data for therapeutic research.

San Francisco, United States
May 2026
Seed

Founder Contacts

19,000+ verified contacts

Advanced MaterialsBiotechnologyGreenTechPackaging ServicesSustainability

LOLIWARE is an award-winning materials tech company dedicated to replacing single-use plastics with seaweed.

San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Swing Therapeutics provides digital therapeutics for people with chronic conditions.

San Francisco, United States
May 2026
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalMental HealthPharmaceutical

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

New York, United States
March 2026
$60.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife Science

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

La Jolla, United States
March 2026
$35.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore Alumni Ventures's Full Portfolio

View all companies funded by Alumni Ventures across every industry and funding stage.

View Full Alumni Ventures Portfolio